Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 4 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Maize and its By-Products - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Maize is one of the most important cereal crops in the world agricultural economy and is grown in many countries in each of the continents of the world. Maize is utilized in more diversified ways than any other cereal. The grain is quite nutritious with a high percentage of easily digested carbohydrates fats and proteins and hardly and deleterious substances. Besides food, maize and maize products have numerous industrial uses such as in adhesives, explosives, soaps and for textile sizing etc. Maize starch is employed in the manufacture of asbestos, ceramics, dyes, plastics, oil, cloth, linoleum, paper, cosmetic and pharmaceutical industries. The derivatives of maize starch included glucose or corn syrup, corn sugar and industrial alcohol which is employed in different industries. It is a highly profitable field with lucrative rate of return. There is good market for new entrepreneurs.
Plant capacity: Starch 4500 MT/Annum, Liquid Glucose 450 MT/Annum, Dextrose Monohydrate 1800 MT/Annum, Oxidised Starch 225 MT/AnnumPlant & machinery: 2 Crores
Working capital: -T.C.I: 5 Crores
Return: 45.00%Break even: 35.00%
Add to Inquiry Add to Inquiry Basket

Liquid Glucose From Maize - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

The maize also called “corn or Indian corn” is widely cultivated in India. Maize ranks high among the four or five principal cereal crops of the world. Maize is utilized in more diversified ways than any other cereal. The grain is quite nutritious, with a high percentage of easily digested carbohydrates, fats and proteins hardly and deleterious substances. Glucose is the form of white crystalline powder. Liquid Glucose or Glucose Syrup is a refined and concentrated non-crystallisable aqueous solution of d-glucose, maltose and other polymers of d-glucose, obtained by controlled hydrolysis of starch containing material. Glucose syrup is used in hard boiled sweets and many dairy products, as a granulating agent for tablet coating and as a vehicle for orally administered medical syrups in pharmaceuticals. It is used in the manufacture of canned food, bakery products, ice-creams, chewing tobacco, shoe polish and leather chemicals. There are various products from maize like maize starch and its by products and direct product of liquid glucose and dextrose from starch. It has good scope in the market.
Plant capacity: 500 tons/AnnumPlant & machinery: 20 Lakhs
Working capital: -T.C.I: 52 Lakhs
Return: 37.00%Break even: 53.00%
Add to Inquiry Add to Inquiry Basket

Maize Processing for Glucose - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Maize is one of the cereal grains which produce through out India and is placed 3rd position in agricultural base production though maize is not our staple basic food but our basic staple foods are wheat and rice : Maize is constitute by hull, germ, protein, starch and moisture. There is dry and wet milling process of manufacturing of starch, zing, germ and hulls. Starch is the basic constituent of maize and it is converted of liquid glucose by adopting series of digestion steps on starch. It is used as sweetener liquid in the pharmaceutical industry. It is used for the manufacturing caramel. It can be used as basic raw material for the fermentation base product like lactic acid, penicillin, acetic acid etc. It has very good market potentiality. New entrepreneurs enter in this field will be successful.
Plant capacity: 15 MT/DayPlant & machinery: 75 Lakhs
Working capital: -T.C.I: 284 Lakhs
Return: 53.00%Break even: 42.00%
Add to Inquiry Add to Inquiry Basket

Surgical Cotton & Bandages

Surgical Bandages are the products manufactured from white bleached Cotton gauge cloth of suitable quality. Absorbent cotton also known as surgical cotton is used mainly for medical purposes. Raw cotton is purified by a series of processed and rendered hydrophile in character beside rendering it free from other external organic impurities. There is an increasing demand for this item in India and has good exporting possibility. Absorbent cotton or medical cotton is used by Doctor, Dentists, industrial safety organizations in Hospitals and for individuals for first aid and home kits. This item is regulated under the drugs Control Act and a manufacturing licence under the provision of the act. There is good scope for new investment. A new entrepreneur may venture in to this field keeping in mind to face the marketing competition.
Plant capacity: 90 Ton Surgical Cotton/Annum, 8 Lakh Nos. Surgical Bandages/AnnumPlant & machinery: 16 Lakhs
Working capital: -T.C.I: 51 Lakhs
Return: 34.00%Break even: 53.00%
Add to Inquiry Add to Inquiry Basket

Acrylic Teeth - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

There is increase of population through out the world. Most of the people has teeth problem in the earlier ages and maximum in the above age of 40 years. The most important factor to consider in the maxillary anterior segment is the vertical height of the alveolar process and its relationship to the proposed final restoration. It is necessary to allot the correct mesiodistal space for each tooth. The clinical and radiographic examinations may contraindicate implant dentistry and indicate a removable or fixed partial denture instead of implant therapy. The site and shape of the available bone are best assessed by the tomographic section. Type of acrylic teeth anterior teeth, anatomic posterior teeth, non-anatomic posterior teeth. There is requirement of synthetic teeth for keeping himself as beautiful. Accordingly there is very good scope for few synthetic teeth maker.
Plant capacity: 1000 Teeth/DayPlant & machinery: 13 Lakhs
Working capital: -T.C.I: 18 Lakhs
Return: 34.00%Break even: 49.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes and Needles Manufacturing - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Production Schedule

With the development of pharmaceutical industries the use of disposable syringes and needles will also develop. With the population growth and lack of balanced food to the people in India, health hazard problems are quite obvious that why pharmaceutical and other medicine related industries like disposable syringes and needle industries are booming day by day. The product has very good domestics and export demand. So it is a good project for the new entrants.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 43.00%Break even: 38.00%
Add to Inquiry Add to Inquiry Basket

Medicated Lozenges Like Strepsils, Tusg - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

Medicated lozenges are made basically by using glucose, water, calcium carbonate, peppermint and some other ingredients. It is used by children to old age people to get the relief from the throat problem. It is same as hard candy having some medicinal effect. Few organized and few in private sectors are engaged in the manufacturing of medicated lozenges. There is 5% growth in demand every year. New entrepreneurs can enter into this field.
Plant capacity: 1 Ton/DayPlant & machinery: 36 Lakhs
Working capital: -T.C.I: 138 Lakhs
Return: 47.00%Break even: 42.00%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 29.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

Medical Alcohol From Date Juice Concentrate - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

Date is one of the best fruits, which contains fructose as sugar ingredients, which is totally fermentable sugar and can be completely converted to ethyl alcohol by fermentation process. There are few expensive fabricating companies who can design the distillery plants and fabricate the plants. There is very good demand of medical alcohol. There is much more demand of it in India also. It is required about 30000000 litres alcohol needed for Homoeopathic medicine only and again it is required for Allopathic medicine. Few new entrepreneurs can venture into this project.
Plant capacity: 10000 Ltrs./DayPlant & machinery: 815 Lakhs
Working capital: -T.C.I: 1264 Lakhs
Return: 30.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

Amla (Gooseberry) Powder - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

Amla powder is largely used for the production of Ayurvedic medicine. There is good demand of the Herbal medicinal product. The dried fruits of E.ribes are used in decoction for fevers and for diseases of the chest and skin. They are also used for ringworm and other skin diseases. It is also used for coughs and diarrhoea. According to the report of W.H.O, over 80% world population relies on traditional medicine largely plant base, for primary healthcare. Unfortunately, Indias share in the global medicinal plants export trade is just 0.5%. There is good scope for new entrepreneurs to venture into this field.
Plant capacity: 600 MT/AnnumPlant & machinery: 52 Lakhs
Working capital: -T.C.I: 154 Lakhs
Return: 38.00%Break even: 63.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 4 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top